Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS) - Derogis, Priscilla Bento Matos; Sanches, Livia Rentas; de Aranda, Valdir Fernandes; Colombini, Marjorie Paris; Mangueira, Cristóvão Luis Pitangueira; Katz, Marcelo; Faulhaber, Adriana Caschera Leme; Mendes, Claudio Ernesto Albers; Ferreira, Carlos Eduardo dos Santos; França, Carolina Nunes; Guerra, João Carlos de Campos (PloS one, 2017)
Keywords: Anticoagulants; Bioavailability; Biology and Life Sciences; Blood Coagulation Tests; Blood plasma; Chromatography; Chromatography, High Pressure Liquid; Drug metabolism; Drug Monitoring; Ethics; Factor Xa Inhibitors - pharmacokinetics; Factor Xa Inhibitors - therapeutic use; High performance liquid chromatography; Human subjects; Humans; Laboratories; Liquid chromatography; Mass spectrometry; Mass spectroscopy; Medical treatment; Medicine and Health Sciences; Methods; Monitoring; Patient outcomes; Patients; Physical Sciences; Physiological aspects; Prevention; Reproducibility of Results; Research and Analysis Methods; Rivaroxaban; Rivaroxaban - pharmacokinetics; Rivaroxaban - therapeutic use; Sample preparation; Scientific imaging; Sensitivity and Specificity; Spectroscopy; Tandem Mass Spectrometry; Testing; Therapeutic drug monitoring; Thromboembolism; Thrombosis; Brazil; Canada; Mexico